Astrazeneca

LIVE: Two SA returnees test Covid positive in Bengaluru; Omicron reaches UK

Two linked cases of the new Omicron coronavirus variant have been detected in Britain connected to travel to southern Africa, health minister Sajid Javid said on Saturday

AstraZeneca Covid booster shot effective against severe disease: UK study

The third dose of AstraZeneca COVID vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer, according to a study in the UK

AstraZeneca says its Covid shot still has role despite global glut

AstraZeneca's COVID-19 vaccine still has a role to play in the fight against the pandemic, even as sales slow and the company charges more in some places, CEO Pascal Soriot said

EU regulator advises AstraZeneca's Covid drug be cleared

The drug was previously cleared by the US Food and Drug Administration in December for people with serious health problems or allergies who can't get adequate protection from vaccination

AstraZeneca Covid drug neutralises Omicron sub-variants in lab study

Evusheld was tested against the BA.1, BA.1.1, and BA.2 sub-variants of Omicron and it was also shown in the study to limit inflammation in the lungs - a critical symptom in severe Covid-19 infections

Short AstraZeneca shelf life complicates vaccine rollout to world's poorest

Many more vaccines are expected to be rejected as African nations and Covax said that from January they would not accept vaccines with less than two-and-a-half months' shelf life

Israel okays AstraZeneca Covid drug for people with weakened immunity

The drug has been shown to reduce severe morbidity and mortality from Covid by 83 per cent

AstraZeneca sees $4 bn in Covid vaccine sales in Q4 as revenue soars

The company recorded full-year revenues of $37.4 billion, an increase of 38% from the year before at constant exchange rates

AstraZeneca booster generates higher antibodies against Omicron: Data

The increased response was seen in people who were previously vaccinated with either Vaxzevria or an mRNA vaccine, the drugmaker said

UK marks Oxford/AstraZeneca Covid-19 vaccine's one-year anniversary

Our fight against COVID in the UK and around the world would not have been possible without the Oxford/AstraZeneca vaccine, said PM Boris Johnson

Oxford-AstraZeneca vaccine behind lower Covid deaths in UK, says expert

'If you look across Europe, with the rise in cases, there's also a corresponding lagged rise in deaths, but not in the UK,' says Dr Clive Dix, former chairman of the UK's Vaccine Task Force

AstraZeneca says its antibody drug Evusheld can fight Omicron variant

Evusheld is one of only two antibody therapies authorised for use that showed neutralising activity against Omicron and against all other variants of concern in these two studies.

Serum Institute on the up as Oxford study backs AstraZ booster for Omicron

Vaxzevria significantly boosts antibodies against the rapidly spreading variant of the coronavirus, shows study

AstraZeneca booster shot effective against Omicron: Oxford lab study

After a three-dose course of the vaccine, neutralising levels against Omicron were similar to those against the virus's Delta variant after two doses

'USFDA study shows Evusheld retains neutralising activity against Omicron'

The study was done independently by investigators at the US Food and Drug Administration (USFDA), Center for Biologics Evaluation and Research.

Billionaire Poonawalla family pledges $66 mn to Oxford for research campus

The pledge builds on the collaboration between Oxford University, AstraZeneca and SII, the world's largest maker of vaccines

Two doses of Covid vax induce lower antibody levels against Omicron: Study

Two doses of Pfizer AstraZeneca Covid vaccines generate lower levels of antibodies against the Omicron variant of coronavirus.

AstraZeneca in touch with Indian authorities for approval to Covid drug

The company said it has initiated engagements with Indian health authorities regarding its Covid prevention drug for people with weakened immune system

US FDA okays AstraZeneca's Covid antibody cocktail for immunocompromised

The US Food and Drug Administration (FDA) has granted emergency use authorisation to AstraZeneca's monoclonal antibody treatment for Covid-19 among people with weakened immune systems.

World's best-performing IPO in 2021 is a Korean bioscience firm

South Korean biopharmaceutical firm SK Bioscience's IPO raised $1.3 billion for the firm, which is a local Covid-19 vaccine-production partner with AstraZeneca Plc.